BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38166581)

  • 1. Incidence, risk factors for active tuberculosis infection and changes of IGRA in patients with Takayasu arteritis: a prospective cohort study.
    Peng Z; Li J; Rong Z; Zhou Y; Wang Y; Wang Y; Zhang G; Yang Y; Tian X; Zeng X
    Emerg Microbes Infect; 2024 Dec; 13(1):2302099. PubMed ID: 38166581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and Risk Factors for Active Tuberculosis in Takayasu Arteritis: A Single-Center Case-Control Study.
    Zhou J; Ji R; Zhu R; Zhou J; Li J; Tian X; Chen Y; Zheng Y
    Front Immunol; 2021; 12():749317. PubMed ID: 34777361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term performance of the IGRA to predict and prevent active tuberculosis development in HIV-infected patients.
    Lee S; Lee JE; Kang JS; Lee SO; Lee SH
    Int J Tuberc Lung Dis; 2019 Apr; 23(4):422-427. PubMed ID: 31064620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Tuberculosis Development in Patients with Rheumatoid Arthritis Receiving Targeted Therapy: a Prospective Single Center Cohort Study.
    Song YJ; Cho SK; Kim H; Kim HW; Nam E; Bae SC; Yoo DH; Sung YK
    J Korean Med Sci; 2021 Mar; 36(10):e70. PubMed ID: 33724737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases.
    Lee CK; Wong SHV; Lui G; Tang W; Tam LS; Ip M; Hung E; Chen M; Wu JC; Ng SC
    J Crohns Colitis; 2018 Jul; 12(8):954-962. PubMed ID: 29757355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Takayasu arteritis and latent or active Mycobacterium tuberculosis infection: a systematic review.
    Pedreira ALS; Santiago MB
    Clin Rheumatol; 2020 Apr; 39(4):1019-1026. PubMed ID: 31729680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of LTBI in patients with autoimmune diseases and accuracy of IGRA in predicting TB relapse.
    Chandrashekara S; Panchagnula R; Chennupati Y
    Rheumatology (Oxford); 2023 Dec; 62(12):3952-3956. PubMed ID: 37348542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis.
    Tang J; Huang Y; Cai Z; Ma Y
    PLoS One; 2021; 16(7):e0254571. PubMed ID: 34270559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of tuberculosis in systemic lupus erythematosus patients: a multi-center prospective cohort study.
    Zhang L; Zou X; Jiang N; Xie L; Liu J; Yang Z; Cao Q; Li C; Sun X; Zhang F; Zhao Y; Zeng X; Shi X; Liu X;
    Front Immunol; 2023; 14():1157157. PubMed ID: 37388724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
    Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of tuberculosis infection among patients with Takayasu arteritis: a meta-analysis of observational studies.
    Li L; Zhou F; Li F; Chen J; Xie X
    Sci Rep; 2023 Dec; 13(1):22481. PubMed ID: 38110470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
    Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
    Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-incubation-time gamma interferon release assays in response to purified protein derivative, ESAT-6, and/or CFP-10 for the diagnosis of Mycobacterium tuberculosis infection in children.
    Schepers K; Mouchet F; Dirix V; De Schutter I; Jotzo K; Verscheure V; Geurts P; Singh M; Van Vooren JP; Mascart F
    Clin Vaccine Immunol; 2014 Feb; 21(2):111-8. PubMed ID: 24152386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factors of Active Tuberculosis Among Hospitalized Patients with Latent Tuberculosis Infection in China: A Cohort Study.
    Liu Y; Zhang L; Chen Y; Ruan G; Liu Y; Chen S; Xie L; Wu F; Shi X; Liu X
    Infect Drug Resist; 2024; 17():953-960. PubMed ID: 38495623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
    Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
    BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.